Physician

Joshua Gordon Ramsay, DO, MBA

According to 2025 Medicare claims, Joshua Ramsay, DO, MBA (NPI: 1093245607) practices hematology/oncology in the Ogden, UT market, with the plurality of this provider's patient population coming from Weber, UT. This provider's primary affiliated billing organization is OGDEN CLINIC SPECIALTY SERVICES LLC (NPI: 1114203668; TIN: 85-3002963) and primary practice location at 84405-7194. Ramsay is affiliated with the Aledade 155 National MSSP (ACO ID: A5358), participating under the MSSP model.

Ramsay's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 417 traditional Medicare patients, billed 148,668 HCPCS/CPT codes, and received $1,608,747 in Medicare payments. The top billing code was 96365 (Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less). Part D data shows 438 prescription claims across 87 beneficiaries totaling $532,573 in drug costs, led by Brukinsa (Zanubrutinib). Open Payments data shows 234 records totaling $6,009. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $2,043 to $532,573. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$804K$1.6M2023 Medicare payment: $385,002 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,608,747 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
202318443,773$385,002
2024417148,668$1,608,747

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$266K$533K2018 Drug cost: $2,043 (USD; Tot_Drug_Cst)2019 Drug cost: $1,203 (USD; Tot_Drug_Cst)2020 Drug cost: $29,249 (USD; Tot_Drug_Cst)2021 Drug cost: $28,473 (USD; Tot_Drug_Cst)2022 Drug cost: $131,467 (USD; Tot_Drug_Cst)2023 Drug cost: $21,257 (USD; Tot_Drug_Cst)2024 Drug cost: $532,573 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20182753$2,043
20191640$1,203
20201455$29,249
20211244$28,473
2022N/R18$131,467
202333107$21,257
202487438$532,573

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
96365Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less116280$46
96372Injection of drug or substance under skin or into muscle95406$11
80053Blood test, comprehensive group of blood chemicals141449$10
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count174761$8
36415Insertion of needle into vein for collection of blood sample140511$7

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
BrukinsaZanubrutinib24720$356,195
EliquisApixaban18643$11,851
Enoxaparin SodiumEnoxaparin Sodium22485$5,898
HydroxyureaHydroxyurea682,175$1,539
Ondansetron OdtOndansetron27722$998

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.225$4,478Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.9$1,531ABBVIE INC.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Joshua Gordon Ramsay, DO, MBA?

Tedicare shows public-source Medicare data for Joshua Gordon Ramsay, DO, MBA (NPI 1093245607), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Joshua Gordon Ramsay, DO, MBA have ACO affiliation data?

Joshua Gordon Ramsay, DO, MBA is shown with ACO affiliation data for Aledade 155 National MSSP (MSSP, ACO ID A5358).

What billing organization is linked to Joshua Gordon Ramsay, DO, MBA?

Joshua Gordon Ramsay, DO, MBA is linked to OGDEN CLINIC SPECIALTY SERVICES LLC (billing NPI 1114203668) in the available physician profile data.

Does Joshua Gordon Ramsay, DO, MBA have Open Payments data?

Joshua Gordon Ramsay, DO, MBA has 234 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.